Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

MYNZ Mainz BioMed NV

6,90

2,13 (44,65%)

21 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Micro Cap Bid Up Following FDA Submission Announcement

A medical company based out of Germany is already turning heads during Tuesday’s premarket hours after the company announced the submission of its application to the U.S....

To read the full story on AllPennyStocks.com, click here.

Mainz BioMed NV (NASDAQ:MYNZ)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Mainz BioMed NV Charts.

Mainz BioMed NV (NASDAQ:MYNZ)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Mainz BioMed NV Charts.

News Mainz BioMed NV

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
Donnerstag 19 Dezember 2024 (2 Tage vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 16 Dezember 2024 (4 Tage vor) • Edgar (US Regulatory)

Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering
Montag 16 Dezember 2024 (4 Tage vor) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Montag 16 Dezember 2024 (5 Tage vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 13 Dezember 2024 (1 Woche vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Freitag 13 Dezember 2024 (1 Woche vor) • Edgar (US Regulatory)

Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules
Freitag 13 Dezember 2024 (1 Woche vor) • GlobeNewswire Inc.

Silexion Is Addressing the MOST COMMON Human Cancer Gene Mutation With RNAi; Recent M&As in the Field Were for Tens of Billions - $SLXN
Mittwoch 11 Dezember 2024 (1 Woche vor) • InvestorsHub NewsWire

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Mittwoch 11 Dezember 2024 (1 Woche vor) • Edgar (US Regulatory)

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Montag 9 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Montag 9 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 29 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Weitere Mainz BioMed NV News-Artikel

Invesco QQQ Trust Series 1

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen